Perspectives
Nature Reviews Drug Discovery 6, 273-286 (April 2007) | doi:10.1038/nrd2115
Opinion: Angiogenesis: an organizing principle for drug discovery?
Judah Folkman1 About the author
Abstract
Angiogenesis — the process of new blood-vessel growth — has an essential role in development, reproduction and repair. However, pathological angiogenesis occurs not only in tumour formation, but also in a range of non-neoplastic diseases that could be classed together as 'angiogenesis-dependent diseases'. By viewing the process of angiogenesis as an 'organizing principle' in biology, intriguing insights into the molecular mechanisms of seemingly unrelated phenomena might be gained. This has important consequences for the clinical use of angiogenesis inhibitors and for drug discovery, not only for optimizing the treatment of cancer, but possibly also for developing therapeutic approaches for various diseases that are otherwise unrelated to each other.
Author affiliations
- Judah Folkman is at the Childrens Hospital and Harvard Medical School Boston, Massachusetts, USA.
Correspondence to: Email: judah.folkman@childrens.harvard.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularizationLaboratory Investigation Research Article
See all 24 matches for Research

